Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 5/20 | 0.42 |
| ▸ | CA6 | P23280 | 5/20 | 0.42 |
| ▸ | CA7 | P43166 | 5/20 | 0.42 |
| ▸ | CA9 | Q16790 | 5/20 | 0.42 |
| ▸ | CA14 | Q9ULX7 | 5/20 | 0.42 |
| ▸ | CA5B | Q9Y2D0 | 5/20 | 0.42 |
| ▸ | CA2 | P00918 | 4/20 | 0.42 |
| ▸ | CA4 | P22748 | 4/20 | 0.42 |
| ▸ | CA5A | P35218 | 4/20 | 0.42 |
| ▸ | LMNA | P02545 | 3/20 | 0.42 |
| ▸ | CA3 | P07451 | 3/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | CA1 | P00915 | 2/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.39 |
| ▸ | CASP2 | P42575 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL37493 | 0.98 | CA12 (0.42) | CA12CA6CA7CA9CA14 | |
| SCHEMBL8582451 | 0.96 | CA12 (0.41) | CA12CA6CA7CA9CA14 | |
| SCHEMBL5505412 | 0.94 | CA12 (0.44) | CA12CA6CA7CA9CA14 | |
| SCHEMBL2866706 | 0.92 | CA12 (0.50) | CA12CA6CA7CA9CA14 | |
| SCHEMBL283229 | 0.92 | CA12 (0.44) | CA12CA6CA7CA9CA14 | |
| SCHEMBL5433206 | 0.91 | CA12 (0.46) | CA12CA6CA7CA9CA14 | |
| SCHEMBL29278475 | 0.86 | CA12 (0.46) | CA12CA6CA7CA9CA14 | |
| SCHEMBL7158315 | 0.86 | CYP1A2 (0.31) | CA12CA6CA7CA9CA14 | |
| SCHEMBL6711996 | 0.86 | CYP2C19 (0.36) | ALDH1A1CYP1A2CYP2C19CASP2MEN1 | |
| SCHEMBL554524 | 0.84 | TSHR (0.48) | ALDH1A1CYP1A2CYP2C19MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108300299-B | Protective coating composition with anti-skid function, coated product and preparation method of coated product | 3M创新有限公司 | 2020-04-28 | — | — | CN | claimed |
| CN-108300299-B | Protective coating composition with anti-skid function, coated product and preparation method of coated product | 3M创新有限公司 | 2020-04-28 | — | — | CN | disclosed |
| US-20160083634-A1 | CURABLE COMPOSITION AND JOINT STRUCTURE PRODUCED USING SAME | SEKISUI FULLER COMPANY, LTD. (JP) | 2016-03-24 | — | — | US | disclosed |
| US-8841105-B2 | Organic-inorganic composite material and process for producing same | NATIONAL UNIVERSITY CORPORATION OKAYAMA UNIVERSITY (JP) | 2014-09-23 | — | — | US | disclosed |
| US-20120034670-A1 | ORGANIC-INORGANIC COMPOSITE MATERIAL AND PROCESS FOR PRODUCING SAME | NATIONAL UNIVERSITY CORPORATION OKAYAMA UNIVERSITY (JP) | 2012-02-09 | — | — | US | disclosed |
| EP-2412677-A1 | ORGANIC-INORGANIC COMPOSITE MATERIAL AND PROCESS FOR PRODUCING SAME | National University Corporation Okayama University (JP) | 2012-02-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120034670-A1 | ORGANIC-INORGANIC COMPOSITE MATERIAL AND PROCESS FOR PRODUCING SAME | RIOX2, MAOA, FTO | CA12 116/4885CA6 130/4885CA7 109/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.